Supplemental Content EBM review of literature - CHM report isotretinoin

Published: 13 July 2023| Version 3 | DOI: 10.17632/hyk3g4ydt2.3
Contributors:
Eugene Tan, Harriet Kennedy, Marius Rademaker

Description

This is a supplementary document with detailed information on the review of the literature cited by the Commission on Human Medicine (CHM) working group on Isotretinoin. Supplementary eTable 1 includes references cited by the CHM and graded according to Oxford EBM level, study type and patient numbers. Supplementary eTable 2 includes the CARM report on isotretinoin and dispensing data from the Pharmaceutical Data Webtool

Files

Categories

Dermatology, Evidence-Based Medicine, Isotretinoin

Licence